REED STEVEN G has a total of 14 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are KISELEV VSEVOLOD IVANOVICH, CHIRON S and NOVARTIS VACCINES & DIAGNOSTICS SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Organic fine chemistry | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Sugars | |
#8 | Unspecified technologies | |
#9 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Reed Steven G | 14 |
#2 | Carter Darrick | 5 |
#3 | Dillon Davin C | 4 |
#4 | Skeiky Yasir A W | 3 |
#5 | Campos-Neto Antonio | 3 |
#6 | Twardzik Daniel R | 3 |
#7 | Vedvick Thomas S | 3 |
#8 | Houghton Raymond | 3 |
#9 | Hendrickson Ronald C | 2 |
#10 | Lodes Michael J | 2 |
Publication | Filing date | Title |
---|---|---|
US2010310602A1 | Synthetic glucopyranosyl lipid adjuvants | |
US2009325204A1 | Compounds and methods for diagnosis and treatment of chagas disease | |
US2009281168A1 | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
US2007081944A1 | Iontophoresis apparatus and method for the diagnosis of tuberculosis | |
WO9317708A1 | Method for treating macrophage pathogen infections | |
WO9316199A1 | PEPTIDE FOR DIAGNOSING AND IMMUNIZING AGAINST T. cruzi INFECTION |